Tuesday, April 25, 2017 | 9:00 AM - 5:00 PM
Keynote Speaker: V. Michael Holers (University of Colorado)
The complement system is the first line of defense against infection, however we have yet to capitalize on its therapeutic potential. This symposium will focus on novel insights into the complement pathway in a number of clinical disorders.
Wednesday, May 24, 2017 | 12:00 PM - 5:00 PM
Speakers: Sean F. Brady (The Rockefeller University), Dirk Trauner (New York University)
The Chemical Biology Discussion Group brings together chemists and biologists interested in discussing the latest breakthroughs. In 2017, the annual year-end meeting features keynote speakers Dr Sean F. Brady and Dr Dirk Trauner.
Tuesday, September 26, 2017 | 9:00 AM - 5:00 PM
Speakers: Nathan J. Baird (National Heart, Lung and Blood Institute, NIH), Matthew D. Disney (Scripps Research Institute), John A. Howe (Merck Research Laboratories), David H. Mathews (University of Rochester), Kevin M. Weeks (University of North Carolina at Chapel Hill), Steven C. Zimmerman (University of Illinois)
This symposium will cover approaches for targeting RNA with small and large molecules. The relevance of RNA splicing, microRNA, and RNA repeat expansions to human disease, and novel approaches for selectively modulating RNA function will be discussed.
Friday, March 3, 2017 | 9:00 AM - 6:30 PM
Keynote Speakers: Kamalika Chaudhuri (University of California San Diego), Tim Roughgarden (Stanford University), and Suchi Saria (Johns Hopkins University)
The 11th Annual Machine Learning Symposium is the latest in a highly successful series bringing together leading researchers from academia and industry to present new algorithms for statistical learning and novel theoretical approaches and discuss applications of ML to real-world data. In addition, the workshop will address limitations of existing techniques and solutions to overcome such shortcomings.
February 21 - 24, 2017
Students will learn to code video games based on simple sensors they control!
Wednesday, November 9, 2016 | 8:30 AM - 5:15 PM
Keynote Speaker: Lawrence D. Mayer (Jazz Pharmaceuticals)
Explore approaches for complex drug development and regulation, outstanding challenges in the assessment of complex drug equivalence, consequences for product interchangeability, and compare biological and non-biological complex drug families.
Tuesday, October 25, 2016 | 9:00 AM - 5:00 PM
Speakers: Marcus Bantscheff (Cellzome/GSK), Benjamin F Cravatt (The Scripps Research Institute), Craig Crews (Yale University), Howard Hang (The Rockefeller University), Ruth Nussinov (National Cancer Institute), Brian Raymer (Pfizer), Bryan Roth (University of North Carolina), Eranthie Weerapana (Boston College)
Chemical Biology is changing the face of drug discovery. This symposium will highlight recent developments in the field, featuring examples from neurobiology and cancer, the ubiquitin proteasome system, GPCRs, and protein lipidation.
Edited by Nabil R. Adams
Big Data can provide insights and drive discovery that will accelerate biomedical advances, improve patient outcomes, and reduce costs.
Keynote Speaker: David Bartel (Whitehead Institute for Biomedical Research, Howard Hughes Medical Institute, MIT)
MicroRNAs (miRNA) play critical roles in regulating gene expression. This symposium presented up-to-date basic, translational, and clinical research addressing the biology of miRNA and their promise as a therapeutic target.
Edited by Xavier Rodó
(Catalan Institute for Climate Sciences)
This Annals issue discusses the latest research on the effects of climate and environmental changes on human health, including on the transmission of infectious diseases and the epidemiology of noncommunicable diseases.
Is there a limit to human knowledge? Where do philosophy and physics intersect? Are we alone in the universe? Answering these and other questions, this six-part series united some of our most vibrant public intellectuals and communicators for explorations that reflect on the current state of modern physical sciences, its greatest mysteries and future endeavors, and its philosophical significance for our understanding of reality and the spiritual dimension of human existence.